Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Patricia Kilian is active.

Publication


Featured researches published by Patricia Kilian.


Immunology Letters | 1989

Human interleukin-1α is chemotactic for normal human keratinocytes

Daniel N. Sauder; F.W. Orr; S. Matic; Dawn K. Stetsko; Kathryn Paganelli Parker; Richard Anthony Chizzonite; Patricia Kilian

Abstract Interleukin-1 (IL-1)has been shown to have mitogenic and chemotactic properties for a variety of cell types includes keratinocytes [1, 2, 19, 20, 23]. These studies suggested that keratinocytes possess receptors for IL-1. In this study, the chemotactic properties of IL-1 for keratinocytes were confirmed and IL-1 receptors were demonstrated on keratinocytes using a radio receptor assay. Crosslinking studies with IL-1α identified two major bands of M r 97 kDa and 133 kDa. Thus, keratinocytes possess high affinity IL-1 receptors and respond to IL-1 by directed migration.


Annual Reports in Medicinal Chemistry | 1985

Chapter 18. Interleukin 1

William R. Benjamin; Peter T. Lomedico; Patricia Kilian

Publisher Summary This chapter discusses the biochemical characterization and the physiological role of interleukin 1 (IL-1). IL-1 is a molecule that possesses a wide variety of biological activities. Biochemical studies reveal that IL-1 produced by stimulated murine macrophages and macrophage tumor cell lines is a single polypeptide chain. Human IL-1 has been shown to be produced by stimulated normal human peripheral blood leukocytes or monocytes, leukemic cells, and a number of human tumor cell lines. Murine and human keratinocytes have been shown to produce an IL-1-like activity designated epidermal T-cell activating factor. This factor exhibits some of the activities of IL-1. IL-1 appears to play a key role in the activation of T-lymphocytes. The processes triggered by IL-1 may include both the secretion of IL-2 and induction of receptors for this growth factor. IL-1 can also modulate B-cell function. However, the nature of the effect can vary depending on the presence of other lymphocyte-derived signals and the type of B-cell stimulus. An effect of IL-1 on fibrinogen and haptoglobin synthesis has also been discussed in the chapter. IL-1 may also be a modulator of the fibroblast proliferation. IL 1 has also significant effects on the cartilage, bone, and synovial membrane. IL-1 is thought to be an important mediator of immune cell interactions and to contribute to a number of disease manifestations and physiological processes. Thus, agents that modulate either IL-1 production or IL-1 activity on the target tissues may be therapeutically beneficial and have been the focus of a number of investigations. This information and additional developments in IL-1 research should lead to an understanding of the mechanism, by which IL-1 induces each of its effector activities, of the role of IL-1 in various disease states and of the means, by which specific activities of IL-1 can be modulated.


Biochimica et Biophysica Acta | 1991

The role of arginine residues in interleukin 1 receptor binding.

Venkata B. Nanduri; Jeffrey David Hulmes; Yu-Ching E. Pan; Patricia Kilian; Alvin S. Stern

Interleukin 1 (IL-1) is a family of polypeptide cytokines that plays an essential role in modulating immune and inflammatory responses. IL-1 activity is mediated by either of two distinct proteins, IL-1 alpha or IL-1 beta, both of which bind to the same receptor found on T-lymphocytes, fibroblasts and endothelial cells (Type 1 receptor). The effect of specific chemical modification of recombinant IL-1 alpha and IL-1 beta on receptor binding was examined. Modification of the proteins with phenylglyoxal, an arginine-specific reagent, resulted in the loss of Type 1 IL-1 receptor binding activity. The stoichiometry of this modification revealed that a single arginine in either IL-1 alpha or IL-1 beta is responsible for the loss of activity. Cyanogen bromide cleavage of phenylglyoxal modified IL-1 alpha and IL-1 beta, followed by sequencing of the peptides, revealed that arginine-12 in IL-1 alpha and arginine-4 in IL-1 beta, which occupy the same topology in the respective crystallographic structures, are the target of phenylglyoxal. These results suggest that an arginine residue plays an important role in ligand-receptor interaction.


Archives of Biochemistry and Biophysics | 1989

Purification to homogeneity and amino acid sequence analysis of a receptor protein for interleukin 1

Alvin S. Stern; Yu-Ching E. Pan; Raina S. Hellmann; Kathryn Paganelli Parker; Dale Mueller; Jeffrey David Hulmes; Patricia Kilian; Richard Anthony Chizzonite

The interleukin 1 (IL-1) receptor from mouse EL-4 thymoma cells was purified to homogeneity by a method which utilized ligand affinity chromatography and classical chromatographic techniques. After solubilization of the receptor from intact cells with the zwitterionic detergent 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, the IL-1 binding activity was purified greater than 23,000-fold. Analysis of the purified protein by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, immunoblot, and ligand blot demonstrated that a single protein of molecular mass of approximately 80 kDa is the IL-1 binding polypeptide. The purified protein bound IL-1 with a dissociation constant of approximately 1.1 X 10(-10) M, which is indistinguishable from the affinity of the cell-bound receptor. The amino acid composition of this protein is strikingly similar to the composition deduced from the sequence of a cDNA coding for an IL-1 receptor from EL-4 cells. Protein sequence analysis of Staphylococcus aureus V-8 protease-derived peptides yields data consistent with the sequence proposed from cloned cDNA. These studies have demonstrated that the high affinity IL-1 receptor on EL-4 cells is the 80-kDa protein.


Archive | 1995

Polyethylene protein conjugates

John Hakimi; Patricia Kilian; Perry Rosen


Archive | 1992

Polyethylene glycol protein conjugates

John Hakimi; Patricia Kilian; Perry Rosen


The American review of respiratory disease | 1990

Increased Levels of Interleukin-1 in Bronchoalveolar Washings from Children with Bacterial Pulmonary Infections

Robert W. Wilmott; Joseph T. Kassab; Patricia Kilian; William R. Benjamin; Steven D. Douglas; Robert E. Wood


Cancer Research | 1991

Antiproliferative Effect of Interleukin-1 on Human Ovarian Carcinoma Cell Line (NIH:OVCAR-3)

Patricia Kilian; Kimberlee L. Kaffka; Denise A. Biondi; Jack M. Lipman; William R. Benjamin; Dorothy Feldman; Carolyn A. Campen


Archive | 1995

Polymer for making poly(ethylene glycol)-protein conjugates

John Hakimi; Patricia Kilian; Perry Rosen


Archive | 1991

Antiproliferative Effect of Interleukin-1 on Human Ovarian Carcinoma Cell Line

Patricia Kilian; Kimberlee L. Kaffka; Denise A. Biondi; Jack M. Lipman; William R. Benjamin; Dorothy Feldman; Carolyn A. Campen

Collaboration


Dive into the Patricia Kilian's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge